Influence of secondary neutrons induced by proton radiotherapy for cancer patients with implantable cardioverter defibrillators.

Influence of secondary neutrons induced by proton radiotherapy for cancer patients with implantable cardioverter defibrillators.
复制标题

DOI:
10.1186/1748-717x-7-10
复制
发表时间:
2012-01-29
期刊:
Radiation oncology (London, England)
影响因子:
--
通讯作者:
Sakurai H
Sakurai H
中科院分区:
其他
文献类型:
--
作者:
Hashimoto T;Isobe T;Hashii H;Kumada H;Tada H;Okumura T;Tsuboi K;Sakae T;Aonuma K;Sakurai H

文献摘要

被引文献

相似文献

虽然质子放射治疗是一种很有前途的新方法,癌症患者,功能干扰是一个问题,植入心脏复律除颤器(ICD)的患者。本研究的目的是阐明质子放射治疗产生的次级中子对ICD的影响。实验装置模拟植入ICD患者的质子放射治疗。四个新的ICD被放置在0.3厘米的横向和3厘米远侧外的辐射领域,以评估二次中子的影响。在10次照射中,累积的野内辐射剂量为107戈伊,剂量率为2戈伊/min,野大小为10 × 10 cm 2。在每次辐射分次后,由ICD程控仪分析治疗对ICD的干扰。用蒙特-卡罗模拟方法估算了次级中子的剂量分布。上电复位的频率(程控起搏模式暂时变为安全备份模式时的最严重软错误)为1/约50戈伊。所有器械中记录的软错误总数为29个,发生率约为每15戈伊1个软错误。未检测到永久性器械故障。体模中每1戈伊质子剂量的次级中子的计算剂量约为1.3-8.9 mSv/戈伊。在本实验设置下,概率约为每50戈伊1次上电复位,低于质子放射治疗中通常使用的剂量水平(60-80戈伊)。需要在各种情况下进行进一步的定量分析,以建立关于植入ICD的癌症患者质子放射治疗的指南。
Although proton radiotherapy is a promising new approach for cancer patients, functional interference is a concern for patients with implantable cardioverter defibrillators (ICDs). The purpose of this study was to clarify the influence of secondary neutrons induced by proton radiotherapy on ICDs. The experimental set-up simulated proton radiotherapy for a patient with an ICD. Four new ICDs were placed 0.3 cm laterally and 3 cm distally outside the radiation field in order to evaluate the influence of secondary neutrons. The cumulative in-field radiation dose was 107 Gy over 10 sessions of irradiation with a dose rate of 2 Gy/min and a field size of 10 × 10 cm2. After each radiation fraction, interference with the ICD by the therapy was analyzed by an ICD programmer. The dose distributions of secondary neutrons were estimated by Monte-Carlo simulation. The frequency of the power-on reset, the most serious soft error where the programmed pacing mode changes temporarily to a safety back-up mode, was 1 per approximately 50 Gy. The total number of soft errors logged in all devices was 29, which was a rate of 1 soft error per approximately 15 Gy. No permanent device malfunctions were detected. The calculated dose of secondary neutrons per 1 Gy proton dose in the phantom was approximately 1.3-8.9 mSv/Gy. With the present experimental settings, the probability was approximately 1 power-on reset per 50 Gy, which was below the dose level (60-80 Gy) generally used in proton radiotherapy. Further quantitative analysis in various settings is needed to establish guidelines regarding proton radiotherapy for cancer patients with ICDs.